Cargando…

Summary of the Comparative Effectiveness Review on Off-Label Use of Atypical Antipsychotics

BACKGROUND: Conventional and atypical antipsychotic medications are approved by the FDA for treatment of schizophrenia and bipolar disorder. Over many decades, the widespread use of conventional antipsychotics produced various side effects requiring additional medications, such as the atypical antip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maher, Alicia R., Theodore, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2012
Materias:	Supplement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438344/ https://www.ncbi.nlm.nih.gov/pubmed/22784311 http://dx.doi.org/10.18553/jmcp.2012.18.S5-B.1

Ejemplares similares

Off-label indications for atypical antipsychotics: A systematic review
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2004)

Off-label use of atypical antipsychotics- Where are we?
por: Vaz, R. P., et al.
Publicado: (2023)

Summary of AHRQ’s Comparative Effectiveness Review of Treatment to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis: Update of the 2007 Report
por: Levis, Silvina, et al.
Publicado: (2012)

Summary of AHRQ’s Comparative Effectiveness Review of Drug Therapy for Rheumatoid Arthritis (RA) in Adults – An Update
por: Singh, Jasvinder A., et al.
Publicado: (2012)

National trends in off-label use of atypical antipsychotics in children and adolescents in the United States
por: Sohn, Minji, et al.
Publicado: (2016)

Methods for Insulin Delivery and Glucose Monitoring in Diabetes: Summary of a Comparative Effectiveness Review
por: Golden, Sherita Hill, et al.
Publicado: (2012)

Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis
por: Yunusa, Ismaeel, et al.
Publicado: (2022)

Summary of AHRQ’s Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis
por: McMahan, Robert, et al.
Publicado: (2012)

AHRQ’s Comparative Effectiveness Research on Oral Medications for Type 2 Diabetes: A Summary of the Key Findings
por: Bennett, Wendy L., et al.
Publicado: (2012)

Updates on the Treatment of Essential Hypertension: A Summary of AHRQ’s Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Direct Renin Inhibitors
por: Powers, Benjamin, et al.
Publicado: (2011)

Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
por: White, Michael, et al.
Publicado: (2011)

An audit into the monitoring of off-label antipsychotics in primary care
por: Rafi, Damir, et al.
Publicado: (2021)

Characteristics and predictors of off‐label use of antipsychotics in general population sample
por: Pirhonen, Eero, et al.
Publicado: (2022)

Off-Label Antipsychotic Prescribing for Persons With Dementia in Assisted Living
por: Wretman, Christopher, et al.
Publicado: (2020)

Prescription Pattern and Off-Label Use of Antipsychotics in a Middle Eastern Population
por: Bastaki, Kholoud, et al.
Publicado: (2021)

Introduction and Executive Summary of the Supplement, Role of Milk and Dairy Products in Health and Prevention of Noncommunicable Chronic Diseases: A Series of Systematic Reviews
por: Gil, Ángel, et al.
Publicado: (2019)

Use of atypical antipsychotics in the elderly: a clinical review
por: Gareri, Pietro, et al.
Publicado: (2014)

Prescribing of Antipsychotic Medication in a Medicaid Population: Use of Polytherapy and Off-Label Dosages
por: Kogut, Stephen J., et al.
Publicado: (2005)

Asenapine: an atypical antipsychotic with atypical formulations
por: Musselman, Meghan, et al.
Publicado: (2021)

Atypical antipsychotics, more than just an antipsychotic
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2020)

Comparative Safety Signal Assessment of Hospitalization Associated With the Use of Atypical Antipsychotics
por: Yunusa, Ismaeel, et al.
Publicado: (2022)

Predictors of Effect of Atypical Antipsychotics on Speech
por: Sinha, Preeti, et al.
Publicado: (2015)

Off-label prescribing of antipsychotics: prescribing practices and clinical experiences of Finnish physicians
por: Rautio, N., et al.
Publicado: (2022)

Guidance on the clinical understanding and use of long‐acting injectable antipsychotics in Schizophrenia: Hong Kong Consensus Statements
por: Wong, Michael Ming Cheuk, et al.
Publicado: (2021)

Treatment of Fast Breathing in Neonates and Young Infants With Oral Amoxicillin Compared With Penicillin–Gentamicin Combination: Study Protocol for a Randomized, Open-label Equivalence Trial
Publicado: (2013)

T207. METABOLIC ADVERSE EFFECTS OF OFF-LABEL USE OF SECOND-GENERATION ANTIPSYCHOTICS IN THE ADULT POPULATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Bowden, Sylvie, et al.
Publicado: (2020)

The use of atypical antipsychotics in Bipolar Spectrum disorders
por: Grünze, H., et al.
Publicado: (2003)

Influence of the use of atypical antipsychotics in metabolic syndrome
por: Doménech-Matamoros, P
Publicado: (2020)

A summary of the controversy surrounding off-label medications in men’s health
por: Parker, Adam, et al.
Publicado: (2016)

Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics
por: Alvarez-Herrera, Samantha, et al.
Publicado: (2020)

Seborrheic Dermatitis: A Case of an Atypical Side Effect of Atypical Antipsychotics
por: Bishay, Ramy, et al.
Publicado: (2023)

Off-label use of antipsychotic medications in psychiatric inpatients in China: a national real-world survey
por: Wang, Juan, et al.
Publicado: (2021)

Antipsychotics in off-label use: prescription practices, benefits and risks Results from APSY Oulu study
por: Jääskeläinen, E.
Publicado: (2023)

Worsening stimulant use disorder outcomes coinciding with off-label antipsychotic prescribing: a commonly unrecognised side effect?
por: Amarasekera, Ruvini, et al.
Publicado: (2023)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Examination of Data, Analytical Issues and Proposed Methods for Conducting Comparative Effectiveness Research Using “Real-World Data”
por: Alemayehu, Demissie, et al.
Publicado: (2011)

AHRQ's Comparative Effectiveness Research on Premixed Insulin Analogues for Adults with Type 2 Diabetes: Understanding and Applying the Systematic Review Findings
por: Qayyum, Rehan, et al.
Publicado: (2011)

Examination of the Evidence for Off-Label Use of Gabapentin
por: Mack, Alicia
Publicado: (2003)

Atypical antipsychotics in bipolar disorder: systematic review of randomised trials
por: Derry, Sheena, et al.
Publicado: (2007)

Comparative Cytochrome P450 In Vitro Inhibition by Atypical Antipsychotic Drugs
por: Gervasini, Guillermo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3ftips53h0j462kdsr1ebrlluj